What is the treatment for left-sided endocarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Left-Sided Endocarditis

The treatment of left-sided endocarditis requires a combination of appropriate antimicrobial therapy for 4-6 weeks along with consideration for early surgical intervention in cases with complications such as heart failure, uncontrolled infection, or high risk of embolism. 1

Antimicrobial Therapy

For Native Valve Endocarditis (NVE)

  • Methicillin-Susceptible Staphylococcus aureus (MSSA):

    • Nafcillin or oxacillin for 6 weeks is recommended for uncomplicated left-sided NVE 1
    • For complicated infections (perivalvular abscess, septic metastatic complications), at least 6 weeks of therapy is required 1
    • Gentamicin should NOT be used for treatment of NVE caused by MSSA 1
  • Methicillin-Resistant Staphylococcus aureus (MRSA):

    • Vancomycin is the recommended treatment 1
    • Daptomycin (≥8-9 mg/kg per dose) may be a reasonable alternative to vancomycin 1
    • Selection of daptomycin dosing should be assisted by infectious diseases consultation 1
  • Streptococcal Endocarditis:

    • For penicillin-sensitive viridans or nonenterococcal group D streptococci: aqueous penicillin G for 4 weeks or combined penicillin and streptomycin for 2 weeks 2
  • Enterococcal Endocarditis:

    • Treatment for 4-6 weeks with aqueous penicillin G together with either streptomycin or gentamicin 2

For Prosthetic Valve Endocarditis (PVE)

  • Early PVE or healthcare-associated IE regimens should cover methicillin-resistant staphylococci, enterococci, and non-HACEK Gram-negative pathogens 1
  • Longer duration of therapy is typically required compared to NVE

Surgical Management

Surgery should be considered in the following scenarios:

Heart Failure Indications (Class I)

  • Aortic or mitral NVE/PVE with severe acute regurgitation, obstruction, or fistula causing refractory pulmonary edema or cardiogenic shock (Emergency surgery) 1
  • Aortic or mitral NVE/PVE with severe regurgitation or obstruction causing symptoms of heart failure or echocardiographic signs of poor hemodynamic tolerance (Urgent surgery) 1

Uncontrolled Infection Indications (Class I)

  • Locally uncontrolled infection (abscess, false aneurysm, fistula, enlarging vegetation) (Urgent surgery) 1
  • Infection caused by fungi or multiresistant organisms (Urgent/elective surgery) 1
  • Persisting positive blood cultures despite appropriate antibiotic therapy (Urgent surgery) 1

Prevention of Embolism Indications (Class I)

  • Persistent vegetations >10 mm after one or more embolic episodes despite appropriate antibiotic therapy (Urgent surgery) 1
  • Large vegetations (>10 mm) with severe valve stenosis or regurgitation and low operative risk (Urgent surgery) 1

Outpatient Parenteral Antibiotic Therapy (OPAT)

OPAT can be considered in two phases:

  • Critical phase (weeks 0-2):

    • Inpatient treatment is preferred during this phase 1
    • OPAT may be considered only for stable patients with uncomplicated infections caused by oral streptococci or Streptococcus bovis 1
  • Continuation phase (beyond week 2):

    • OPAT can be considered if the patient is medically stable 1
    • OPAT should NOT be used if the patient has heart failure, concerning echocardiographic features, neurological signs, or renal impairment 1

Recent Advances

  • Partial oral antibiotic therapy may be considered for stable patients with left-sided endocarditis after at least 10 days of intravenous antibiotics, based on the POET trial 3
  • This approach was found to be non-inferior to continued intravenous treatment in selected stable patients 3

Common Pitfalls and Caveats

  • Avoid gentamicin for MSSA/MRSA native valve endocarditis due to increased risk of nephrotoxicity without improved outcomes 1
  • In cases of brain abscess resulting from MSSA IE, nafcillin should be used instead of cefazolin due to better blood-brain barrier penetration 1, 4
  • For patients with a well-defined history of non-anaphylactoid reactions to penicillins, a first-generation cephalosporin such as cefazolin may be reasonable 1
  • Up to 50% of patients with IE will require cardiothoracic surgical intervention, so early consultation with a cardiac surgeon is essential 5, 1
  • Vancomycin is often considered inferior to β-lactams for MSSA infections, so β-lactam allergy evaluation should be conducted whenever vancomycin is considered 1

Monitoring

  • Regular clinical assessment for signs of heart failure, embolic events, or neurological complications 1
  • Repeat blood cultures to confirm clearance of bacteremia 5
  • Echocardiographic follow-up to monitor vegetation size and valvular function 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antibiotic treatment of infective endocarditis.

Annual review of medicine, 1983

Research

Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis.

The New England journal of medicine, 2019

Guideline

Treatment of Right-Sided Endocarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Endocarditis.

Primary care, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.